How to buy Moderna stock (MRNA)

Our top picks for where to buy Moderna stock

Buy Moderna stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AS SEEN ON:

Moderna is a biotechnology business based in the US. Moderna shares (MRNA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $40.13 – an increase of 1.88% over the previous week. Moderna employs 5,600 staff and has a trailing 12-month revenue of around $5.1 billion.

Moderna stock price (NASDAQ: MRNA)

Use our graph to track the performance of MRNA stocks over time.

Moderna shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$40.13
52-week range	$35.80 - $170.47
50-day moving average more info button	$46.00
200-day moving average more info button	$90.63
Wall St. target price	$74.19
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-5.81

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Moderna stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Moderna price performance over time

Historical closes compared with the close of $40.43 from 2024-12-26

1 week (2024-12-20)	2.64%
1 month (2024-11-29)	-6.11%
3 months (2024-09-27)	-38.51%
6 months (2024-06-28)	-65.95%

1 year (2023-12-28)	-59.07%
2 years (2022-12-28)	-77.09%
3 years (2021-12-28)	241.44
5 years (2019-12-27)	107.12%

Moderna financials

Revenue TTM	$5.1 billion
Gross profit TTM	$10.6 billion
Return on assets TTM	-9.55%
Return on equity TTM	-17.52%
Profit margin	-43.77%
Book value	$30.98
Market Capitalization more info button	$15.5 billion

TTM: trailing 12 months

Moderna share dividends

We're not expecting Moderna to pay a dividend over the next 12 months.

Moderna share price volatility

Over the last 12 months, Moderna's shares have ranged in value from as little as $35.8 up to $170.47. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Moderna's is 1.69. This would suggest that Moderna's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Moderna overview

Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co. , Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S. p.

Frequently asked questions

What percentage of Moderna is owned by insiders or institutions?
Currently 9.524% of Moderna shares are held by insiders and 71.643% by institutions. How many people work for Moderna?
Latest data suggests 5,600 work at Moderna. When does the fiscal year end for Moderna?
Moderna's fiscal year ends in December. Where is Moderna based?
Moderna's address is: 200 Technology Square, Cambridge, MA, United States, 02139 What is Moderna's ISIN number?
Moderna's international securities identification number is: US60770K1079 What is Moderna's CUSIP number?
Moderna's Committee on Uniform Securities Identification Procedures number is: 60770K107